Furthermore, erdosteine has shown a synergism with antibiotic therapy. In stable COPD patients, long-term treatment with erdosteine had a protective effect against exacerbations by reducing the ...

In summary, physician and/or patient preference will probably guide the treatment ... antibiotics (RR: 2.86; 95% CI: 1.06–7.76). This article demonstrates that in exacerbations of COPD ...

The Company continues to anticipate that the totality of its early-stage research programs will comprise less than 20% of overall expenditure.

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...

The UK is poised to become the first country in the world to launch a new payment model for antibiotics that could ... the way for a pipeline of future treatment options." Grifols has filed ...